BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) approval for its BD Totalys MultiProcessor and BD Totalys SlidePrep instruments.
{iframe}http://www.meddeviceonline.com/doc/bd-receives-fda-approval-for-new-automated-cervical-cancer-screening-system-0001{/iframe}